Mass Spectrometry Assay Targets Toxic Light Chains in AL Amyloidosis
Protego Biopharma presented data on AmyLiteDx, a mass spectrometry assay for analyzing toxic light chains in AL amyloidosis, and on early NT-proBNP changes as a signal of cardiac response, at the 2026 International Symposium on Amyloidosis.
Read More